Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pituitary Tumor: early-phase trial registry
4 of 6 indexed Pituitary Tumor trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Pituitary Tumor: 6 US clinical trials tracked, 4 recruiting.
Pituitary Tumor is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lori Wood, running 1 of these trials.
Enrollment posture brief
Registry condition pituitary-tumor
OPEN 4 | RECR 67% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Pituitary Tumor lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pituitary Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pituitary Tumor is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pituitary Tumor research.
Lori Wood accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Pituitary Tumor enrolment sits around 292 participants.
Median target enrolment is 292 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Pituitary Tumor splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Pituitary Tumor Surveillance: Pathogenic Correlation
Cedars-Sinai Medical Center
NCT00599092
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
NCT04087902
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
Lori Wood
NCT05659524
Evaluation of the CONVIVO System
Dartmouth-Hitchcock Medical Center
NCT05139277
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Memorial Sloan Kettering Cancer Center
NCT04042753
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Columbia University
NCT01556230
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pituitary Tumor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pituitary Tumor trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pituitary Tumor page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Pituitary Tumor trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Lori Wood sponsors the most Pituitary Tumor trials on record, review their full trial history before evaluating a specific study. See Lori Wood's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pituitary Tumor condition card totals 6 registered trials; most-linked intervention Radiotherapy for CNFA; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.